Skip to main content
Peer Review

Peer Reviewed

Empirical Research

Sex Differences in Osteomyelitis of the Foot in Persons With Diabetes Mellitus: A Meta-Analysis

April 2021
Wound Management & Prevention 2021;67(5):19–25 doi:10.25270/wmp.2021.5.1925

Abstract

BACKGROUND: Osteomyelitis of the foot is a risk factor for amputation in persons with diabetes mellitus. There is some evidence to suggest that patient sex affects the risk of diabetes-related foot complications. PURPOSE: To examine the effect of sex on osteomyelitis risk in patients with diabetic foot disease. METHODS: Systematic searches of PubMed and the China National Knowledge Infrastructure were performed from inception through May 2020 using the terms “diabetic foot” and “osteomyelitis.” Original research studies including persons with diabetes mellitus, diabetic foot disease, or ulcers as well as reports of osteomyelitis were included. Study quality was assessed according to the Newcastle–Ottawa Scale. The pooled odds ratio (OR) and 95% confidence interval (CI) for osteomyelitis were calculated by sex. RESULTS: Nine (9) studies from 6 countries involving 2583 patients met the inclusion criteria for analysis. No significant publication bias was observed. The average age of patients was 65.2 years, and 32.03% of men and 30.0% of women were diagnosed with osteomyelitis. The pooled OR was 1.14 (95% CI, 0.94-1.38; P = .76). Regression analysis (t = -0.61; P > .561) showed no association between the incidence of osteomyelitis and ORs. CONCLUSION: This meta-analysis suggests that patient sex does not affect the odds of having osteomyelitis among persons with diabetes and diabetic foot disease or ulcers.

Introduction

Osteomyelitis of the foot is a common complication of infection in persons with diabetes mellitus. Usually starting in a wound and the soft tissues, it often involves cortical bone and/or bone marrow.1 Approximately 20% of infected foot ulcers in patients with diabetes are complicated by osteomyelitis.2 Osteomyelitis is the main risk factor of amputation in patients with diabetic foot disease.3 In a retrospective comparative case series, Wukich et al4 showed that the total amputation rate of patients with diabetic foot disease and osteomyelitis was 5.6 times higher than that of patients without osteomyelitis.

Many risk factors of osteomyelitis of the foot in persons with diabetes mellitus have been investigated. Mutluoglu et al,5 who performed a retrospective study by reviewing the records of patients with diabetes who were admitted to a medical center with infected foot wounds over a 2-year period, reported that risk factors for osteomyelitis in a multivariate model included the following: length of hospital stay, total duration of antibiotic therapy, duration of intravenous antibiotic therapy, and minor amputation. Patient sex was not a risk factor (male: female odds ratio [OR] = 1.17; 95% confidence interval [CI], 0.45-2.95). The prospective study conducted by Lavery et al,6 which included 1666 persons with diabetes and foot wounds who presented to a managed care diabetes disease management program, also showed that male sex was not a risk factor for osteomyelitis (pooled OR = 1.25; 95% CI, 0.63-2.53). In addition, multidrug-resistant organism infection, previous antibiotic therapy, and wound area > 4 cm2 were shown to be risk factors regardless of sex in the investigation conducted by Huang et al,7 which included medical records of 372 patients with diabetes and infected foot wounds who were admitted to the hospital between January 2011 and December 2014. However, Schwegler et al8 conducted a prospective study in 20 patients with diabetic foot ulcers and found a higher incidence of osteomyelitis in men than in women (pooled OR = 2.14; 95% CI, 0.30-15.36). Tang et al3 published a meta-analysis that investigated sex differences in amputation risk in patients with diabetes and found that the risk of amputation in men was about 1.5 times higher than in women (OR = 1.67; 95% CI, 1.307-2.149).

The purpose of this meta-analysis was to examine if sex was a risk factor for developing osteomyelitis in patients with diabetes mellitus and foot disease.

Methods

Database and study selection. To identify all studies, electronic databases including the China National Knowledge Infrastructure and PubMed were searched systematically from their inception to May 2020. The search terms were “diabetic foot” and “osteomyelitis.” No limitations were imposed regarding language or publication status. A total of 541 records were identified through PubMed, and 391 through China National Knowledge Infrastructure. Additional records were identified through meeting abstracts (n = 5). The grey literature, which includes conferences and workshop proceedings as well as ongoing trials, also was reviewed (n = 2).

Inclusion criteria were 1) patients with diabetes and foot disease or ulcers, 2) patients diagnosed with osteomyelitis of the foot, and 3) ORs of osteomyelitis risk stratified by sex were provided or could be calculated from the reported variables. Exclusion criteria included 1) osteomyelitis not caused by or related to foot disease or ulcers, 2) preclinical studies, and 3) reviews, case reports, and case series. Full-text reviews were performed by 2 independent reviewers based on these criteria.

Data extraction and qualitative assessment. A self-designed abstraction form was used to retrieve data including first author, publication year, study design, hemoglobin A1C (HbA1c) value (%), and diagnostic criteria of osteomyelitis. All data were independently extracted by 2 reviewers to identify potentially eligible studies. Any discrepancy was resolved through discussion between the reviewers.

The quality of studies was assessed according to the Newcastle–Ottawa Scale (NOS). Selection, comparability, and exposure are the 3 dimensions in the NOS. The NOS score ranges from 0 to 9 stars. A maximum of 1 star can be awarded to each numbered item in the selection and exposure categories; a maximum of 2 stars can be awarded for comparability. Studies scoring 7 or more (corresponding to 78% of the maximum score) were regarded as having good quality.

Statistical analysis. All statistical analyses were performed with Stata15.0 (Stata Corp, College Station, TX). Either a fixed or a random effects model was applied, according to the heterogeneity test, which was explored by inconsistency (I2) statistics (P < .5, for I2 value of 50% or more represented substantial heterogeneity). Heterogeneity was judged to be low (< 25%), moderate (25–75%), or high (> 75%). ORs and 95% CIs were estimated with a fixed model or a random effects model and were graphically displayed in forest plots. Subgroup analysis was performed for 2 study designs. Publication bias was investigated based on funnel plots.9 Sensitivity analyses were conducted to evaluate the consistency of the primary results after omitting 1 study at a time to examine its influence on the pooled ORs. Meta-regression was conducted to examine the relationships among the incidence of osteomyelitis and OR.10

Results

Study descriptions. Of the 939 original articles that were retrieved from the databases, the authors identified 9 studies1, 5-8, 11-14 that met the inclusion criteria; these 9 studies encompassed 2583 patients. The selection process is shown in Figure 1.15 Of the 9 studies, 4 were conducted in China and 1 each were conducted in the United States, the United States and the United Kingdom, Hungary, Italy, and Switzerland. Seven (7) studies (89.7% of patients) were retrospective cohort studies, and 2 studies (10.3% of patients) were prospective cohort studies. There were 663 persons (25.7%) who had osteomyelitis secondary to foot ulcers. Characteristics of the studies, such as design, country, participants, diagnostic criteria of osteomyelitis, and diabetes duration, are presented in Table 1. HbA1c (%) of patients was 8.50 to 9.27. Patient age ranged from 58.4 to 71.0 years, with a mean age of 65.2 years.

Meta-analysis of pooled ORs and sensitivity analyses. Nine (9) studies provided enough information for pooled ORs. Data were pooled by the use of the fixed effects model because the heterogeneity test was insignificant (I2 = 0.00% in all comparisons). When comparing male to female as the reference group, the pooled OR was 1.14 (95% CI, 0.94-1.38; P =.766), which was not statistically significant (Figure 2). There was no evidence of publication bias based on funnel (Figure 3).

Sensitivity analysis tested the stability of the results. The included studies were removed one by one to observe the change of the combined effect after each study was removed. Pooled estimates and conclusions were consistent with the primary analysis (Figure 4).

The authors compared the incidence of osteomyelitis to ORs by regression analysis, with the graph (t = -0.61, P > .561) suggesting that ORs were not associated with the incidence of osteomyelitis (Figure 5). In addition, ORs were not affected by the year of the research studies, according to the graph of regression analysis (P > 0.203; t = -0.14) (Figure 6).

Risk of bias assessment of included studies. The quality rating of the included studies ranged from 6 to 8 stars on the NOS. All 9 studies had a low risk of bias for the following parameters: population, outcomes measured, follow-up time, and appropriate statistical analysis. All studies had a control group.

Discussion

This meta-analysis found no sex differences in osteomyelitis in patients with diabetes mellitus and diabetic foot disease, with males and females having an almost equivalent possibility of osteomyelitis (pooled OR = 1.14; 95% CI, 0.94-1.38; P = .766). In the studies, 32.03% of men and 30.0% of women had osteomyelitis.

The results of the current study are consistent with the results of Mutluoglu et al5 and Lavery et al.6 Mutluoglu et al,5 who performed a 2-year retrospective study by reviewing the records of persons with diabetes mellitus hospitalized with a foot ulcer, found that sex was not a risk factor for osteomyelitis. The prospective study conducted by Lavery et al,6 which included 1666 persons with diabetes who presented to a managed care diabetes disease management program, also showed that sex differences were not a risk factor for osteomyelitis. In a prospective observation study in 20 patients with diabetes and foot ulcers, Schwegler et al8 found that osteomyelitis was more prevalent in male compared with female patients (pooled OR = 2.14; 95% CI, 0.30-15.36).

It is not entirely clear why the risk of osteomyelitis in this population does not differ between males and females. According to Albright and Fleischer,16 patients who received a preventive foot examination within the past year were 33% less likely to be hospitalized within that year. In 2012, Pscherer et al17 found that more women made more appointments for preventive care and were more active in self-care practices than men. Laclé and Valero-Juan18 believed that men had barriers associated with access to health care, specifically men’s reluctance to seek medical care if they did not perceive themselves to be critically ill. However, results of a descriptive cross-sectional study by Hirpha et al19 found that 73% of patients inspected their feet more than once per day and 19.5% inspected their feet daily, and no significant differences in self-care practices were seen between women and men. Similarly, a cross-sectional study by AlOwais and Shido20 showed that more than 65% of patients were certain about their knowledge regarding foot self-care, and the scores of a foot self-care knowledge test did not differ by participant sex.

Senneville21 suggests that the health care system should develop a primary health care strategy to help ensure that patients with diabetes learn good foot self-care. In addition, Meizheng et al22 suggested that clinicians should inform patients to be alert to the occurrence of osteomyelitis and other adverse phenomena, and strive to achieve early detection and timely treatment.22 The International Working Group on the Diabetic Foot also provides a variety of evidence-based prevention suggestions, which can help reduce the risk of foot ulcers.23 When physical examination findings are combined with results from plain radiographs, magnetic resonance imaging, and serum inflammatory markers,24 both the accuracy and reliability of early stage diagnosis increase.25

Limitations

There are a number of limitations in this meta-analysis. First, 7 of the 9 studies included were retrospective investigations, which have inherent limitations compared with prospective studies. Second, studies with small sample sizes were included. Third, the 9 studies had different diagnostic criteria for osteomyelitis, because current criteria for diagnosis are not universally agreed upon. This may have affected the results.

Conclusions

A meta-analysis was conducted to examine if sex was a risk factor for developing osteomyelitis in patients with diabetes mellitus and foot disease. Analysis of the data included in 9 studies (2583 patients) did not show a significant difference. Persons with diabetes mellitus are at risk of diabetic foot disease and osteomyelitis and should receive comprehensive follow-up care, including education about foot self-care practices and early detection of complications.

Affiliations

Dr. Chen is a professor and Ms. Zhang, Ms. Wang, Ms. Zhao, and Mr. Li are undergraduate students, Nantong University, Nantong City, Jiangsu Province, China. Address all correspondence to Hong-Lin Chen, PhD, School of Public Health, Nantong University, Nantong City, Jiangsu Province, China; email: 3214460881@qq.com.

References

1. Lauf L, Ozsvár Z, Mitha I, et al. Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis. Diagn Microbiol Infect Dis. 2014;78(4):469–480. doi:10.1016/j.diagmicrobio.2013.12.007

2. Hutting KH, de Stegge WBA, van Netten JJ, et al. Surgical treatment of diabetic foot ulcers complicated by osteomyelitis with gentamicin-loaded calcium sulphate-hydroxyapatite biocomposite. J Clin Med. 2021;10(2):371–391. doi:10.3390/jcm10020371

3. Tang Z-Q, Chen H-L, Zhao F-F. Gender differences of lower extremity amputation risk in patients with diabetic foot: a meta-analysis. Int J Low Extrem Wounds. 2014;13(3):197–204. doi:10.1177/1534734614545872

4. Wukich DK, Hobizal KB, Sambenedetto TL, Kirby K, Rosario BL. Outcomes of osteomyelitis in patients hospitalized with diabetic foot infections. Foot Ankle Int. 2016;37(12):1285–1291. doi:10.1177/1071100716664364

5. Mutluoglu M, Sivrioglu AK, Eroglu M, et al. The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds. Scand J Infect Dis. 2013;45(7):497–503. doi:10.3109/00365548.2013.765589

6. Lavery LA, Peters EJ, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract. 2009;83(3):347–352. doi:10.1016/j.diabres.2008.11.030

7. Huang Y, Cao Y, Zou MC, et al. [Distribution of pathogens in diabetic foot osteomyelitis and risk factors of osteomyelitis]. J South Med Univ. 2015;35(12):1782–1786.

8. Schwegler B, Stumpe KD, Weishaupt D, et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Intern Med. 2008;263(1):99–106. doi:10.1111/j.1365-2796.2007.01877.x

9. Doleman B, Freeman SC, Lund JN, Williams JP, Sutton AJ. Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: presentation of a new publication bias test. Res Synth Methods. 2020;11(4):522–534. doi:10.1002/jrsm.1414

10. Lynch HN, Zu K, Kennedy EM, et al. Corrigendum to “Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.” Environ Int. 2017;109:195–196. doi:10.1016/j.envint.2017.10.004

11. Guo J. Study on the prevalence and risk factors of amputation in patients with diabetic foot osteomyelitis. Dissertation. Tianjin Medical University; 2013. 

12. Tascini C, Gemignani G, Palumbo F, et al. Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis. J Chemother. 2006;18(6):648–651. doi:10.1179/joc.2006.18.6.648

13. Zhang H. Analysis of risk factors of diabetic foot complicated with osteomyelitis in patients with type 2 diabetes mellitus. Feet Health Care. 2019;219:39–40. doi:10.19589/j.cnki.issn1004-6569.2019.13.039

14. Li HM, Qian WJ, Liu JP, Meng JS. Analysis of clinical features and MR signs of diabetic foot osteomyelitis. J Med Imaging. 2020;30(1):163–165. 

15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3(e123-e130).

16. Albright RH, Fleischer AE. Association of select preventative services and hospitalization in people with diabetes. J Diabetes Complications. 2021;3:107903. doi:10.1016/j.jdiacomp.2021.107903

17. Pscherer S DF, Lauterbach S, Kostev K. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes. 2012;6:241–246. doi:10.1016/j.pcd.2012.02.004

18. Laclé A, Valero-Juan LF. Diabetes-related lower-extremity amputation incidence and risk factors: a prospective seven-year study in Costa Rica. Rev Panam Salud Publica. 2012;32(3):192–198. doi:10.1590/s1020-49892012000900004

19. Hirpha N, Tatiparthi R, Mulugeta T. Diabetic foot self-care practices among adult diabetic patients: a descriptive cross-sectional study. Diabetes Metab Syndr Obes. 2020;13:4779–4886. doi:10.2147/DMSO.S285929

20. AlOwais MM, Shido OA. Knowledge and practice of foot care in patients with diabetes mellitus attending primary care center at Security Forces Hospital, Riyadh, Saudi Arabia: a cross-sectional study. J Family Med Prim Care. 2020;9(12):5954–5960. doi:10.4103/jfmpc.jfmpc_943_20

21. Senneville E. Editorial commentary: probe-to-bone test for detecting diabetic foot osteomyelitis: rapid, safe, and accurate–but for which patients? Clin Infect Dis. 2016;63(7):949–950. doi:10.1093/cid/ciw450

22. Meizheng L, Yutao L, Yingzhu LU, Fengling WU. Analysis on risk factors for diabetic foot and osteomyelitis in patients with type 2 diabetes mellitus. Clin Med Engineering. 2019;26(3):414–416. doi:10.3969/j.issn.1674-4659.2019.03.0414 

23. Bus SA, van Netten JJ, Lavery LA, et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab Res Rev. 2016 ;32(suppl 1):16–24. doi:10.1002/dmrr.2696

24. Miao W-W, Chen H-L. (99m) Tc-Ceftizoxime in diagnosis of diabetic foot osteomyelitis: more evidences are needed. J Med Imaging Radiat Oncol. 2019;63(3):352. doi:10.1111/1754-9485.12867

25. Wilson BM, Bessesen MT, Doros G, et al. Adjunctive rifampin therapy for diabetic foot osteomyelitis in the veterans health administration. JAMA Netw Open. 2019;2(11):e1916003. doi:10.1001/jamanetworkopen.2019.16003